Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Biochemical FP Assay from US Patent US12016863: "Inhibitors of RSV replication and applications thereof"
Assay data:4 Active, 16 Tested
Summary
Plaque Reduction Assay from US Patent US11634425: "Pharmaceutical compounds"
Assay data:124 Active, 124 Activity ≤ 1 µM, 124 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of Authentic Filovirus Infections in Cell Culture Assays from US Patent US11459308: "Broad spectrum inhibitors of filoviruses"
Assay data:35 Active, 10 Activity ≤ 1 µM, 44 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Inhibition of Infectivity of Recombinant VSVs Expressing Glycoproteins from Zaire Ebolavirus, Sudan Ebolavirus, Bundybugyo Ebolavirus, and Lassa Arenavirus from US Patent US11459308: "Broad spectrum inhibitors of filoviruses"
Assay data:56 Active, 14 Activity ≤ 1 µM, 74 Tested
RSV-A Assay from US Patent US11420976: "Heterocyclic compounds as anti-viral agents"
Assay data:40 Active, 67 Activity ≤ 1 µM, 67 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µM
SARS-CoV-2 antiviral assay from WIPO Patent WO2022081973: "PHOSPHOLIPID COMPOUNDS AND USES THEREOF"
Assay data:71 Active, 67 Activity ≤ 1 µM, 71 Tested
Ebola Antiviral Assay (EBOV) from US Patent US11149049: "Substituted nucleosides, nucleotides and analogs thereof"
Assay data:5 Active, 4 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
n vitro cytoprotection assay from US Patent US10752598: "Aryldiazepine derivatives as RSV inhibitors"
Assay data:8 Active, 20 Tested
SummaryCompounds, Active
Antiviral activity against RSV infected in human HEL 299 cells assessed as inhibition of virus-induced cytopathogenic effect incubated for 3 to 7 days by MTS assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 12 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against Measles virus infected in African green monkey Vero cells assessed as reduction in viral cytopathic effect
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against SUDV infected in human HeLa cells assessed as reduction in viral cytopathic effect
Antiviral activity against Marburg virus infected in human HeLa cells assessed as reduction in viral cytopathic effect
Antiviral activity against Ebola virus infected in human HeLa cells assessed as reduction in viral cytopathic effect
Antiviral activity against Measles virus
Antiviral activity against Marburgvirus Angola infected in African green monkey Vero cells
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
Antiviral activity against Zaire ebolavirus infected in African green monkey Vero cells
Antiviral activity against Measles virus CC infected in African green monkey Vero 76 cells by neutral red dye based analysis
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Antiviral activity against Measles virus CC infected in African green monkey Vero 76 cells by visual analysis
Antiviral activity against RSV
Assay data:1 Tested
SummaryPubMed Citation
Antiviral activity against Zaire ebolavirus infected in African green monkey Vero cells assessed as reduction in virus induced cytopathic effect preincubated with cells for 1 hr followed by viral infection and measured after 48 hrs
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on